Utah Medical Products, Inc. (UTMD)
USD 62.0
(-0.85%)
USD 62.0
(-0.85%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 135.45 Million USD | 9.35% |
| 2022 | 123.87 Million USD | 7.19% |
| 2021 | 115.56 Million USD | 3.41% |
| 2020 | 111.74 Million USD | 1.78% |
| 2019 | 109.78 Million USD | 10.04% |
| 2018 | 99.76 Million USD | 7.57% |
| 2017 | 92.74 Million USD | 21.1% |
| 2016 | 76.58 Million USD | -3.27% |
| 2015 | 79.17 Million USD | -2.34% |
| 2014 | 81.07 Million USD | 0.45% |
| 2013 | 80.71 Million USD | 4.91% |
| 2012 | 76.93 Million USD | 0.71% |
| 2011 | 76.38 Million USD | 85.24% |
| 2010 | 41.23 Million USD | -1.24% |
| 2009 | 41.75 Million USD | 7.56% |
| 2008 | 38.82 Million USD | -15.58% |
| 2007 | 45.98 Million USD | 4.07% |
| 2006 | 44.18 Million USD | 6.11% |
| 2005 | 41.64 Million USD | 0.92% |
| 2004 | 41.26 Million USD | -16.97% |
| 2003 | 49.69 Million USD | 112.49% |
| 2002 | 23.38 Million USD | -0.78% |
| 2001 | 23.57 Million USD | -7.28% |
| 2000 | 25.42 Million USD | -8.41% |
| 1999 | 27.75 Million USD | -13.26% |
| 1998 | 32 Million USD | 1.59% |
| 1997 | 31.5 Million USD | 9.0% |
| 1996 | 28.9 Million USD | -13.21% |
| 1995 | 33.3 Million USD | 21.53% |
| 1994 | 27.4 Million USD | -3.18% |
| 1993 | 28.3 Million USD | 1.07% |
| 1992 | 28 Million USD | 30.84% |
| 1991 | 21.4 Million USD | 37.18% |
| 1990 | 15.6 Million USD | 31.09% |
| 1989 | 11.9 Million USD | 20.2% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 135.44 Million USD | -0.01% |
| 2024 Q3 | 129.69 Million USD | -0.26% |
| 2024 Q2 | 130.03 Million USD | -3.99% |
| 2023 Q2 | 130.47 Million USD | 2.12% |
| 2023 Q4 | 135.45 Million USD | 3.21% |
| 2023 Q3 | 131.24 Million USD | 0.59% |
| 2023 Q1 | 127.77 Million USD | 3.15% |
| 2023 FY | 135.45 Million USD | 9.35% |
| 2022 Q3 | 118.41 Million USD | 1.95% |
| 2022 Q1 | 119.8 Million USD | 3.67% |
| 2022 FY | 123.87 Million USD | 7.19% |
| 2022 Q4 | 123.87 Million USD | 4.61% |
| 2022 Q2 | 116.14 Million USD | -3.05% |
| 2021 Q1 | 114.38 Million USD | 2.37% |
| 2021 Q2 | 116.79 Million USD | 2.1% |
| 2021 Q4 | 115.56 Million USD | -3.5% |
| 2021 FY | 115.56 Million USD | 3.41% |
| 2021 Q3 | 119.75 Million USD | 2.53% |
| 2020 FY | 111.74 Million USD | 1.78% |
| 2020 Q1 | 103.19 Million USD | -6.01% |
| 2020 Q2 | 103.54 Million USD | 0.34% |
| 2020 Q3 | 107.07 Million USD | 3.41% |
| 2020 Q4 | 111.74 Million USD | 4.36% |
| 2019 Q3 | 104.09 Million USD | 0.71% |
| 2019 Q2 | 103.36 Million USD | -1.61% |
| 2019 Q1 | 105.05 Million USD | 5.3% |
| 2019 FY | 109.78 Million USD | 10.04% |
| 2019 Q4 | 109.78 Million USD | 5.47% |
| 2018 Q2 | 97.04 Million USD | -0.15% |
| 2018 Q4 | 99.76 Million USD | 0.62% |
| 2018 Q3 | 99.15 Million USD | 2.17% |
| 2018 FY | 99.76 Million USD | 7.57% |
| 2018 Q1 | 97.18 Million USD | 4.79% |
| 2017 Q1 | 82.16 Million USD | 7.29% |
| 2017 FY | 92.74 Million USD | 21.1% |
| 2017 Q4 | 92.74 Million USD | 2.28% |
| 2017 Q3 | 90.67 Million USD | 5.5% |
| 2017 Q2 | 85.94 Million USD | 4.6% |
| 2016 Q2 | 81.04 Million USD | -2.61% |
| 2016 Q3 | 82.81 Million USD | 2.19% |
| 2016 Q4 | 76.58 Million USD | -7.53% |
| 2016 Q1 | 83.21 Million USD | 5.1% |
| 2016 FY | 76.58 Million USD | -3.27% |
| 2015 Q2 | 79.93 Million USD | 6.04% |
| 2015 FY | 79.17 Million USD | -2.34% |
| 2015 Q1 | 75.37 Million USD | -7.03% |
| 2015 Q4 | 79.17 Million USD | -1.22% |
| 2015 Q3 | 80.15 Million USD | 0.28% |
| 2014 FY | 81.07 Million USD | 0.45% |
| 2014 Q4 | 81.07 Million USD | -1.47% |
| 2014 Q2 | 84.29 Million USD | 1.69% |
| 2014 Q1 | 82.89 Million USD | 2.7% |
| 2014 Q3 | 82.28 Million USD | -2.38% |
| 2013 FY | 80.71 Million USD | 4.91% |
| 2013 Q3 | 80.59 Million USD | 5.46% |
| 2013 Q2 | 76.42 Million USD | 0.09% |
| 2013 Q1 | 76.36 Million USD | -0.74% |
| 2013 Q4 | 80.71 Million USD | 0.14% |
| 2012 Q2 | 76.88 Million USD | -3.86% |
| 2012 FY | 76.93 Million USD | 0.71% |
| 2012 Q3 | 78.8 Million USD | 2.5% |
| 2012 Q1 | 79.96 Million USD | 4.68% |
| 2012 Q4 | 76.93 Million USD | -2.37% |
| 2011 Q4 | 76.38 Million USD | -3.38% |
| 2011 Q3 | 79.05 Million USD | -2.11% |
| 2011 FY | 76.38 Million USD | 85.24% |
| 2011 Q1 | 81.9 Million USD | 98.61% |
| 2011 Q2 | 80.76 Million USD | -1.39% |
| 2010 FY | 41.23 Million USD | -1.24% |
| 2010 Q1 | 43.94 Million USD | 5.24% |
| 2010 Q2 | 43.08 Million USD | -1.95% |
| 2010 Q3 | 44.21 Million USD | 2.61% |
| 2010 Q4 | 41.23 Million USD | -6.72% |
| 2009 Q1 | 40.78 Million USD | 5.05% |
| 2009 Q3 | 42.17 Million USD | 4.16% |
| 2009 Q4 | 41.75 Million USD | -1.01% |
| 2009 Q2 | 40.49 Million USD | -0.71% |
| 2009 FY | 41.75 Million USD | 7.56% |
| 2008 Q2 | 45.98 Million USD | -2.02% |
| 2008 FY | 38.82 Million USD | -15.58% |
| 2008 Q1 | 46.93 Million USD | 2.05% |
| 2008 Q3 | 45.9 Million USD | -0.18% |
| 2008 Q4 | 38.82 Million USD | -15.42% |
| 2007 Q4 | 45.98 Million USD | -0.35% |
| 2007 FY | 45.98 Million USD | 4.07% |
| 2007 Q2 | 44.85 Million USD | -1.61% |
| 2007 Q3 | 46.14 Million USD | 2.87% |
| 2007 Q1 | 45.59 Million USD | 3.19% |
| 2006 Q3 | 43.46 Million USD | 3.21% |
| 2006 Q1 | 42.24 Million USD | 1.44% |
| 2006 Q2 | 42.11 Million USD | -0.31% |
| 2006 Q4 | 44.18 Million USD | 1.66% |
| 2006 FY | 44.18 Million USD | 6.11% |
| 2005 Q2 | 36.91 Million USD | -9.21% |
| 2005 Q4 | 41.64 Million USD | 12.47% |
| 2005 FY | 41.64 Million USD | 0.92% |
| 2005 Q3 | 37.02 Million USD | 0.3% |
| 2005 Q1 | 40.65 Million USD | -1.46% |
| 2004 Q3 | 44.16 Million USD | -4.63% |
| 2004 Q4 | 41.26 Million USD | -6.57% |
| 2004 Q1 | 47.22 Million USD | -4.97% |
| 2004 FY | 41.26 Million USD | -16.97% |
| 2004 Q2 | 46.3 Million USD | -1.95% |
| 2003 FY | 49.69 Million USD | 112.49% |
| 2003 Q1 | 23.76 Million USD | 1.63% |
| 2003 Q2 | 24.02 Million USD | 1.07% |
| 2003 Q4 | 49.69 Million USD | 101.75% |
| 2003 Q3 | 24.63 Million USD | 2.54% |
| 2002 Q4 | 23.38 Million USD | -4.3% |
| 2002 FY | 23.38 Million USD | -0.78% |
| 2002 Q1 | 23.42 Million USD | -0.62% |
| 2002 Q2 | 24.14 Million USD | 3.05% |
| 2002 Q3 | 24.43 Million USD | 1.23% |
| 2001 Q1 | 24.46 Million USD | -3.76% |
| 2001 Q4 | 23.57 Million USD | -2.81% |
| 2001 Q3 | 24.25 Million USD | 0.29% |
| 2001 Q2 | 24.18 Million USD | -1.16% |
| 2001 FY | 23.57 Million USD | -7.28% |
| 2000 Q1 | 27.7 Million USD | -0.17% |
| 2000 Q4 | 25.42 Million USD | -1.99% |
| 2000 Q2 | 27.2 Million USD | -1.81% |
| 2000 FY | 25.42 Million USD | -8.41% |
| 2000 Q3 | 25.93 Million USD | -4.66% |
| 1999 Q4 | 27.75 Million USD | -3.96% |
| 1999 FY | 27.75 Million USD | -13.26% |
| 1999 Q2 | 29.3 Million USD | -2.66% |
| 1999 Q3 | 28.9 Million USD | -1.37% |
| 1999 Q1 | 30.1 Million USD | -5.94% |
| 1998 Q3 | 34.8 Million USD | 13.36% |
| 1998 Q4 | 32 Million USD | -8.05% |
| 1998 FY | 32 Million USD | 1.59% |
| 1998 Q2 | 30.7 Million USD | -0.97% |
| 1998 Q1 | 31 Million USD | -1.59% |
| 1997 FY | 31.5 Million USD | 9.0% |
| 1997 Q1 | 27.7 Million USD | -4.15% |
| 1997 Q2 | 27.6 Million USD | -0.36% |
| 1997 Q3 | 33.7 Million USD | 22.1% |
| 1997 Q4 | 31.5 Million USD | -6.53% |
| 1996 Q3 | 29.2 Million USD | 8.55% |
| 1996 Q2 | 26.9 Million USD | -25.28% |
| 1996 Q1 | 36 Million USD | 8.11% |
| 1996 Q4 | 28.9 Million USD | -1.03% |
| 1996 FY | 28.9 Million USD | -13.21% |
| 1995 Q4 | 33.3 Million USD | 3.74% |
| 1995 Q1 | 28.7 Million USD | 4.74% |
| 1995 Q2 | 29.2 Million USD | 1.74% |
| 1995 Q3 | 32.1 Million USD | 9.93% |
| 1995 FY | 33.3 Million USD | 21.53% |
| 1994 Q3 | 25.7 Million USD | 4.05% |
| 1994 Q4 | 27.4 Million USD | 6.61% |
| 1994 Q1 | 28.9 Million USD | 2.12% |
| 1994 FY | 27.4 Million USD | -3.18% |
| 1994 Q2 | 24.7 Million USD | -14.53% |
| 1993 Q3 | 29.4 Million USD | -4.55% |
| 1993 Q2 | 30.8 Million USD | 0.33% |
| 1993 Q1 | 30.7 Million USD | 9.64% |
| 1993 Q4 | 28.3 Million USD | -3.74% |
| 1993 FY | 28.3 Million USD | 1.07% |
| 1992 Q2 | 25 Million USD | 5.49% |
| 1992 Q1 | 23.7 Million USD | 10.75% |
| 1992 FY | 28 Million USD | 30.84% |
| 1992 Q4 | 28 Million USD | 4.09% |
| 1992 Q3 | 26.9 Million USD | 7.6% |
| 1991 Q1 | 16.9 Million USD | 8.33% |
| 1991 FY | 21.4 Million USD | 37.18% |
| 1991 Q2 | 17.7 Million USD | 4.73% |
| 1991 Q3 | 19.5 Million USD | 10.17% |
| 1991 Q4 | 21.4 Million USD | 9.74% |
| 1990 Q3 | 14.6 Million USD | 6.57% |
| 1990 Q4 | 15.6 Million USD | 6.85% |
| 1990 Q2 | 13.7 Million USD | 7.87% |
| 1990 Q1 | 12.7 Million USD | 6.72% |
| 1990 FY | 15.6 Million USD | 31.09% |
| 1989 FY | 11.9 Million USD | 20.2% |
| 1989 Q2 | 10.9 Million USD | 0.0% |
| 1989 Q3 | 10.2 Million USD | -6.42% |
| 1989 Q4 | 11.9 Million USD | 16.67% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 24.9% |
| AngioDynamics, Inc. | 317.67 Million USD | 57.359% |
| AtriCure, Inc. | 613.93 Million USD | 77.936% |
| Avinger, Inc. | 13.77 Million USD | -883.718% |
| Azenta, Inc. | 2.88 Billion USD | 95.306% |
| BioLife Solutions, Inc. | 412.71 Million USD | 67.179% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 98.838% |
| Daxor Corporation | 34.86 Million USD | -288.475% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -368.421% |
| Femasys Inc. | 27.75 Million USD | -388.034% |
| GlucoTrack, Inc. | 4.9 Million USD | -2661.631% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 1.389% |
| Hologic, Inc. | 9.15 Billion USD | 98.521% |
| ICU Medical, Inc. | 4.37 Billion USD | 96.906% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.123% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -375.943% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 60.938% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -2078.215% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -2078.215% |
| Masimo Corporation | 3.04 Billion USD | 95.546% |
| Microbot Medical Inc. | 8.32 Million USD | -1526.732% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 21.207% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 94.174% |
| Nephros, Inc. | 11.86 Million USD | -1042.045% |
| NovoCure Limited | 1.14 Billion USD | 88.181% |
| NEXGEL, Inc. | 9.95 Million USD | -1260.703% |
| NEXGEL, Inc. | 9.95 Million USD | -1260.703% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 48.974% |
| OraSure Technologies, Inc. | 482.84 Million USD | 71.946% |
| Pro-Dex, Inc. | 54.21 Million USD | -149.876% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -122.778% |
| Predictive Oncology Inc. | 14.41 Million USD | -839.555% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -700.931% |
| QuidelOrtho Corporation | 8.56 Billion USD | 98.418% |
| Repligen Corporation | 2.82 Billion USD | 95.204% |
| Sanara MedTech Inc. | 73.87 Million USD | -83.371% |
| STAAR Surgical Company | 488.69 Million USD | 72.282% |
| Sharps Technology, Inc. | 11.78 Million USD | -1048.994% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 98.162% |
| Jin Medical International Ltd. | 32.9 Million USD | -311.683% |